Employment Agreement between NeoGenomics, Inc. and Robert J. Shovlin



 EXHIBIT 10.1 

EMPLOYMENT AGREEMENT 

THIS EMPLOYMENT AGREEMENT (“Agreement”) is made this 18th day of September, 2014 by and between NeoGenomics, Inc. a Nevada
corporation (“NeoGenomics” or the “Employer” and collectively with any entity that is wholly or partially owned by NeoGenomics, the “Company”), located at 12701 Commonwealth Drive, Suite #5, Fort
Myers, Florida 33913 and Robert J. Shovlin (“Executive”), an individual who resides at 15 Pine Tree Road, Ramsey, NJ 07446. 

RECITALS: 
 WHEREAS,
the Company is engaged in the business of providing genetic and molecular diagnostic testing services to doctors, hospitals and other healthcare institutions; and 

WHEREAS, NeoGenomics desires to employ Executive as an officer in the capacity of Chief Operating Officer, and Executive desires to be
employed by NeoGenomics in such capacity, in accordance with the terms, covenants, and conditions as set forth in this Agreement. 
 NOW,
THEREFORE, in consideration of the mutual promises set forth herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Employer and Executive agree as follows: 

1. Employment and Term. Subject to the terms and conditions set forth in this Agreement, the Company hereby offers and the Employee hereby
accepts employment beginning on October 13, 2014, or such other date as may be mutually agreed upon in writing (the “Effective Date”). The Employee’s employment with the Company will be “at will” as such term is
construed under Florida law. Either the Employee or the Company may terminate such employment at any time and for any reason, subject to the provisions of Section 5 hereof. For purposes of this Agreement, the period from the Effective Date
until the termination of the Executive’s employment shall hereinafter be referred to as the “Term”. 
 2. Position and
Duties. 
 a) Position. During the Term hereof, Executive shall serve the Company as the Chief Operating Officer
(“COO”) of both NeoGenomics, Inc., the parent company, and NeoGenomics Laboratories, Inc., the primary operating subsidiary, or such other position or positions as the Company may in the future determine, at such location or
locations as the Company may determine after consultation with the Executive. Executive will report to and be subject to the general supervision and direction of the Chief Executive Officer (“CEO”) of the Company. If requested,
Executive will serve in similar capacities for each or any subsidiary of NeoGenomics without additional compensation. 
 b)
Duties. Executive shall perform such duties as are customarily performed by someone holding the title of COO in the same or similar businesses or enterprises as that engaged in by the Company and such other duties as the CEO may assign
from time to time. Executive shall devote his full business time and his best efforts, business judgment, skill and knowledge exclusively to the advancement of the business and interests of the Company and its affiliates and to the discharge of his
duties and responsibilities hereunder. Executive shall not engage in any other business activity or serve in any industry, trade, professional, governmental or academic position during the Term, except as may be expressly in advance by the Board of
Directors of the Company (the “Board”) in writing; provided, however, that Executive may, without advance approval, participate in charitable activities and passive personal activities, provided that such activities do not,
individually or in the aggregate, interfere with the performance of Executive’s duties under this Agreement, are not in conflict with the business interests of the Company or any of its affiliate, and do not violate the terms of that certain
Confidentiality, Non-Solicitation and Non-Compete Agreement attached hereto as Addendum A. 

  
 1 








 c) Compliance with Policies, Practices, etc. During the Term hereof, Executive
shall comply with all Company policies, practices and procedures and all codes of ethics and or business conduct as may be in effect for officers of the Company from time to time. 

3. Compensation and Benefits of Executive. The Company shall compensate Executive for Executive’s services rendered under this Agreement as
follows: 
  

	 	a)	Base Salary. Unless otherwise adjusted by the Compensation Committee of the Board (the “Compensation Committee”), the Company shall pay Executive a base salary of $325,000 per annum (the
“Base Salary”), payable in equal installments at such times as is consistent with normal Company payroll policy. 

  

	 	b)	Bonus. Executive will be eligible for a performance-based bonus as a participant in the Company’s Management Incentive Plan (“MIP”), which shall set annual target incentives for the
Executive and other senior ranking employees that are determined by the Compensation Committee. The Company will target an annual bonus of up to 40% of the Executive’s Base Salary (the “Target Bonus”), with the actual amount of
the bonus, if any, to be determined by and in the sole discretion of the Compensation Committee after consideration of specified metrics established by the Board or the Compensation Committee for such fiscal year. Executive shall be eligible to
receive up to 150% of the Target Bonus in the event that the Company’s and/or the Executive’s performance exceeds the thresholds set for the Target Bonus. Except as otherwise agreed to by the parties in writing, Executive must be employed
hereunder on the last day of a fiscal year in order to be eligible for a bonus for such fiscal year. 

  

	 	c)	Benefits. Subject to the eligibility requirements (including, but not limited to, participation by part-time employees), and enrollment provisions of the Company’s employee benefit plans, Executive
may, to the extent he so chooses, participate in any and all of the Company’s employee benefit plans, at the Company’s expense. All Company benefits are identified in the Employee Handbook and are subject to change without notice or
explanation. In addition, subject to the eligibility requirements (including, but not limited to, participation by a part-time employee) and enrollment provisions of the Company’s executive benefit programs, Executive shall also be entitled to
participate in any and all other benefits programs established for officers of the Company. 

  

	 	d)	Stock Options. On the Effective Date, Executive will be granted an option to purchase 300,000 shares of the Company’s common stock (the “Options”) on the terms and conditions listed
below. Such Options will have a strike price equal to the fair market value of the common stock as of the Effective Date, which pursuant to NeoGenomics’ Amended and Restated Equity Incentive Plan (the “Plan”), shall be equal to
the closing price per share of NeoGenomics’ common stock on the last trading day immediately preceding the Effective Date. The vesting provisions of such Options shall be as outlined below. These Options shall be treated as incentive stock
options (ISOs) to the maximum extent permitted under applicable law, and the remainder of the Options, if any, shall be treated as non-qualified stock options. The grant of these Options will be made pursuant to the Company’s Plan and will be
evidenced by a separate “Option Agreement” to be executed by the Company and Executive, which will contain all the terms and conditions of the Options (including, but not limited to, the provisions set forth in this
Section 3(d)). So long as Executive remains employed by the Company, such Options will have a five (5) year term before expiration. 


  
 2 









					
	 Vesting
	 	  	 
	 	75,000	  	  	will vest on the first anniversary of the Effective Date
		
	 	6,250	  	  	will vest each month beginning on the 13th monthly anniversary of the Effective Date and continuing on each monthly anniversary thereafter until the fourth anniversary of the
Effective Date

  

	 	  	Executive understands that, pursuant to the Plan, upon termination of his employment, he will only have ninety (90) days to exercise any vested portion of the Options. All Options awarded pursuant to this
Section 3(d) will contain a provision in the Option Agreement that allows for immediate vesting of any unvested portion of the Options in the event of that a change of control of NeoGenomics is consummated on or after the first anniversary of
the Effective Date. In the event of that a change of control of NeoGenomics is consummated prior to the first anniversary of the Effective Date, half of any remaining unvested Options shall be deemed vested. 


 

	 	e)	Paid Time-Off and Holidays. Executive’s paid time-off (“PTO”) and holidays shall be consistent with the standards set forth in the Company’s Employee Handbook, as revised from
time to time or as otherwise published by the Company. Notwithstanding the previous sentence, Executive will be eligible for one hundred sixty (160) hours of PTO/year, which will accrue on a pro-rata basis throughout the year, provided,
however, that it is the Company’s policy that no more than forty (40) hours of PTO can be accrued beyond this annual limit for any employee at any time. Thus, when accrued PTO reaches two hundred (200) hours, Executive will cease
accruing PTO until accrued PTO is one hundred sixty (160) hours or less, at which point Executive will again accrue PTO until he reaches two hundred (200) hours. In addition to PTO, there are also six (6) paid national holidays and
one (1) “floater” day available to Company employees. Executive agrees to schedule such PTO so that it minimally interferes with the Company’s operations. Such PTO does not include Board excused absences. 


 

	 	f)	Reimbursement of Normal Business Expenses. The Company will reimburse all reasonable business expenses of Executive, including, but not limited to, cell phone expenses and business related travel, meals
and entertainment expenses in accordance with the Company’s polices for such reimbursement. 

 4. Termination. The parties
agree that any termination of the Executive under this Agreement will be governed as follows: 
  

	 	a)	By the Company for Cause. The Company shall have the right to terminate this Agreement and to discharge the Executive for Cause (as defined below), at any time during the Term. For the purposes of this
Agreement, the Company shall have “Cause” to terminate the Executive’s employment hereunder upon: 

 (i)
failure to materially perform and discharge the duties and responsibilities of Executive under this Agreement after receiving written notice and allowing Executive ten (10) business days to create a plan to cure such failure(s), such plan being
acceptable to the Board of Directors, and a further thirty (30) days to cure such failure(s), if so curable, provided, however, that after one such notice has been given to Executive and the thirty (30) day cure period has lapsed,
the Company is no longer required to provide time to cure subsequent failures under this provision, or 

  
 3 








 (ii) any breach by Executive of the material provisions of this Agreement; or 

(iii) misconduct which, in the good faith opinion and sole discretion of the Board of Directors, is injurious to the Company; or 

(iv) felony conviction involving the personal dishonesty or moral turpitude of Executive; or a determination by the Board, after consideration
of all available information, that Executive has willfully and knowingly violated Company policies or procedures involving discrimination, harassment, or work place violence; or 

(v) engagement in illegal drug use or alcohol abuse which prevents Executive from performing his duties in any manner, or 

(vi) any misappropriation, embezzlement or conversion of the Company’s opportunities or property by the Executive; or 

(vii) willful misconduct, recklessness or gross negligence by the Executive in respect of the duties or obligations of the Executive under this
Agreement and/or the Confidentiality, Non-Solicitation or Non-Competition Agreement. 
  

	 	  	Any termination for Cause pursuant to this Section shall be given to the Executive in writing and shall set forth in detail all acts or omissions upon which the Company is relying to terminate the Executive for Cause.
If an Executive is terminated for Cause, the Executive shall only be entitled to receive his accrued and unpaid Salary, bonus and other benefits through the termination date and the Company shall have no further obligations under this Agreement from
and after the date of termination. 

  

	 	b)	Termination by Company Without Cause. At any time during the Term, the Company shall have the right to terminate this Agreement and to discharge the Executive without Cause effective upon delivery of
written notice to the Executive. If the Company terminates the Executive without “Cause” for any reason, then the Company agrees that as severance it will continue to pay the Executive’s Base Salary in accordance with
Section 3(a) (the “Severance Payments”) for twelve (12) months from the date of the notice of termination. Executive further agrees that in the event that he obtains employment during any period where Severance Payments
are being made, he will promptly notify the Company of the nature of his new employment. Provided that such employment does not violate the terms of the Confidentiality, Non-Solicitation and Non-Compete Agreement, such Severance Payments will
continue to be paid. Other than the Severance Payments, the Company shall have no further obligation to the Executive after the date of such termination; provided, however, that the Executive shall only be entitled to continuation of the
Severance Payments as long as he is in compliance with the provisions of the Confidentiality, Non-Solicitation & Non-Compete Agreement, which is part of this Agreement. If termination without cause shall occur at any time, then the pro rata
portion of any unvested time-based options (as specified in Section 3(d)) up until the date of notice of termination that are due to vest in the year or month of termination shall vest. 


 

	 	  	The Executive acknowledges and agrees that any and all payments to which he would be entitled under this Paragraph 5b are conditioned upon and subject to his execution of a general waiver and release, in such reasonable
form as counsel for the Company shall determine, of all claims the Executive has or may have against the Company. 


  
 4 









	 	c)	By Resignation of the Executive. The Executive may terminate his employment hereunder, upon giving sixty (60) days written notice to the Company. The Executive agrees that, unless otherwise agreed
upon in writing, during such sixty (60) day period no more than one week of unused PTO may be utilized and that all other unused PTO up to the time of termination shall be forfeited. In the event of such a termination, the Executive shall
comply with any reasonable request of the Company to assist in providing for an orderly transition of authority, but such assistance shall not delay the Executive’s termination of employment longer than the Executive’s original notice of
termination. Upon such a termination, the Executive shall become entitled to any accrued but unpaid salary and other benefits up to and including the date of termination and the pro rata portion of any unvested time-based options (as specified in
Section 3(d)) up until the date of separation that are due to vest in the year or month of separation shall vest. 

  

	 	d)	Disability of the Executive. This Agreement may be terminated by the Company upon the Disability of the Executive. “Disability” shall mean any mental or physical illness, condition, disability or
incapacity which prevents the Executive from reasonably discharging his duties and responsibilities under this Agreement for a period of ninety (90) days in any one hundred eighty (180) day period. In the event that any disagreement or
dispute shall arise between the Company and the Executive as to whether the Executive suffers from any Disability, then, in such event, the Executive shall submit to the physical or mental examination of a physician licensed under the laws of the
State of Florida, who is agreeable to the Company and the Executive, and such physician shall determine whether the Executive suffers from any Disability. In the absence of fraud or bad faith, the determination of such physician shall be final and
binding upon the Company and the Executive. The entire cost of such examination shall be paid solely by the Company. In the event the Company has purchased disability insurance for Executive, the Executive shall be deemed disabled if he is disabled
as defined by the terms of the disability policy. On the date that the Executive is deemed to have a Disability, this Agreement will be deemed to have been terminated and the Executive shall be entitled to receive from the Company his accrued and
unpaid Base Salary, bonus and other benefits through the termination date. If a termination of the Executive by Disability shall occur at any time, then the pro rata portion of any unvested time-based options (as specified in Section 3(d)) up
until the date of the Executive’s termination that were due to vest in the year or month of the Executive’s termination shall vest. Other than as set forth in the immediately preceding two sentences, the Company shall have no further
salary or bonus payment or other benefits obligations under this Agreement from and after the date of termination due to Disability. 

  

	 	e)	Death of the Executive. In the event of the death of Executive, the employment of the Executive by the Company shall automatically terminate on the date of the Executive’s death and the Company shall
be obligated to pay Executive’s estate (i) the Executive’s accrued and unpaid Base Salary, bonus and other benefits through the termination date. If the death of the Executive shall occur at any time, than the pro rata portion of any
unvested time-based options up until the date of the Executive’s death that were due to vest in the year or month of the Executive’s death shall vest. Other than as set forth in the immediately preceding two sentences, the Company shall
have no further obligations under this Agreement from and after the date of termination due to the death of the Executive. 


  
 5 








 5. Effect of Termination. The provisions of this Section 5 shall apply to any termination of
the Executive’s employment under this Agreement, whether pursuant to Section 4 or otherwise. 
  

	 	a)	Provision by the Company of Severance Payments, if any, due to the Executive in accordance with this Agreement shall constitute the entire obligation of the Company to the Executive hereunder. The Executive shall
promptly give the Company notice of all facts necessary for the Company to determine the amount and duration of its obligations in connection with any termination pursuant to this Agreement. 


 

	 	b)	Except for any right of the Executive to continue medical, vision, or dental plan participation in accordance with applicable law or as expressly provided herein, the Executive’s participation in all Employee
Benefit Plans shall terminate pursuant to the terms of the applicable plan documents based on the date of termination of the Executive’s employment without regard to any Severance Payments, notice required hereunder, or any other payment made
to or on behalf of the Executive following such date of termination. 

  

	 	c)	Provisions of this Agreement shall survive any termination of the Executive’s employment if so provided herein or if necessary or desirable fully to accomplish the purposes of other surviving provisions, including
without limitation the obligations of the Executive under the Confidentiality, Non-Solicitation & Non-Compete Agreement. The obligation of the Company to provide Severance Payments hereunder is expressly conditioned on the Executive’s
continued full compliance with the terms of the Confidentiality, Non-Compete & Non-Solicitation Agreement. The Executive acknowledges that, except as expressly provided in Section 4(b), no compensation is earned after termination of
employment. 

 6. Confidentiality, Non-Solicitation & Non-Compete Agreement. Executive agrees to the terms of the
Confidentiality, Non-Solicitation and Non-Compete Agreement attached hereto as Addendum A and has signed that Agreement. Such Confidentiality, Non-Solicitation and Non-Compete Agreement is hereby incorporated into and made a part of this
Agreement. 
 7. Importance of Certain Clauses. Executive and Employer agree that the covenants contained in the Confidentiality,
Non-Solicitation and Non-Compete Agreement attached hereto and incorporated into this Agreement are material terms of this Agreement and all parties understand the importance of such provisions to the ongoing business of the Employer. As such,
because the Employer’s continued business and viability depend on the protection of such secrets and non-competition, these clauses are interpreted by the parties to have the widest and most expansive applicability as may be allowed by law and
Executive understands and acknowledges his or her understanding of same. 
 8. Consideration. Executive acknowledges and agrees that the
provision of employment under this Agreement and the execution by the Employer of this Agreement constitute full, adequate and sufficient consideration to Executive for the Executive’s duties, obligations and covenants under this Agreement and
under the Confidentiality, Non-Solicitation and Non-Compete Agreement incorporated into this Agreement. 
 9. Acknowledgement of Post Termination
Obligations. Upon the effective date of termination of Executive’s employment (unless due to Executive’s death), if requested by the Employer, Executive shall participate in an exit interview with the Employer and certify in
writing that Executive has complied with his contractual obligations and intends to comply with his continuing obligations under this Agreement, including, but not limited to, the terms of the Confidentiality, Non-Solicitation and Non-Compete
Agreement. To the extent it is known or applicable at the time of such exit interview, Executive shall also provide the Employer with information concerning Executive’s subsequent employer and the capacity in which Executive will be employed.
Executive’s failure to comply shall be a material breach of this Agreement, for which the Employer, in addition to any other civil remedy, may seek equitable relief. 

  
 6 








 10. Withholding. All payments made to Executive shall be made net of any applicable withholding for
income taxes and Executive’s share of FICA, FUTA or other employment taxes. The Company shall withhold such amounts from such payments to the extent required by applicable law and remit such amounts to the applicable governmental authorities in
accordance with applicable law. 
 11. Representations of Executive. Executive represents and warrants to NeoGenomics that (a) nothing in
his past legal and/or work and/or personal experiences, which if became broadly known in the marketplace, would impair his ability to serve as the Chief Operating Officer of a publicly-traded company or materially damage his credibility with public
shareholders; (b) he has not been convicted of any criminal offense related to health care, or been debarred, sanctioned, excluded or otherwise made ineligible for participation in a federal or state health care program by any federal or state
agency; (c) there are no restrictions, agreements, or understandings whatsoever to which he is a party which would prevent or make unlawful his execution of this Agreement or employment hereunder, (d) Executive’s execution of this
Agreement and his employment hereunder shall not constitute a breach of any contract, agreement or understanding, oral or written, to which he is a party or by which he is bound, (e) Executive is free and able to execute this Agreement and to
continue employment with NeoGenomics, and (f) Executive has not used and will not use confidential information or trade secrets belonging to any prior employers to perform services for the Company. 

12. Compliance Agreements. Executive agrees to provide services to the Company in compliance with all applicable federal and state laws and
regulations, as well as all compliance guidance published by federal or state agencies, including, without limitation, the Medicare and Medicaid anti-kickback law, the Stark self-referral prohibition, and compliance guidance published by the Office
of the Inspector General of the Department of Health and Human Service, and to assist the Company in remaining educated and in compliance with respect to such laws and regulations and compliance guidance. Executive acknowledges that he understands
these requirements, and shall remain educated and informed regarding the applicable federal and state laws and regulations, as well as all compliance guidance published by federal or state agencies. In the event that Executive knows or suspect that
any activities of the Company or any personnel or contractor of the Company, or any client of the Company implicates any such requirements or guidance, he agrees that he will immediately inform the Chief Executive Officer of the Company and
cooperate fully with the Company to investigate and address any compliance issues arising as a result of such known or suspected activities. Executive further understands and acknowledges that compliance with this paragraph shall be a condition of
employment. 
 13. Effect of Partial Invalidity. The invalidity of any portion of this Agreement shall not affect the validity of any other
provision. In the event that any provision of this Agreement is held to be invalid, the parties agree that the remaining provisions shall remain in full force and effect. 

14. Entire Agreement. This Agreement, together with the other documents referenced herein, reflects the complete agreement between the parties
regarding the subject matter identified herein and shall supersede all other previous agreements, either oral or written, between the parties. The parties stipulate that neither of them, nor any person acting on their behalf has made any
representations except as are specifically set forth in this Agreement and each of the parties acknowledges that it or he has not relied upon any representation of any third party in executing this Agreement, but rather have relied exclusively on it
or his own judgment in entering into this Agreement. 
 15. Assignment. Employer may assign its interest and rights under this Agreement at its
sole discretion and without approval of Executive to a successor in interest by the Employer’s merger, consolidation or 

  
 7 








 
other form of business combination with or into a third party where the Employer’s stockholders before such event do not control a majority of the resulting business entity after such event.
All rights and entitlements arising from this Agreement, including but not limited to those protective covenants and prohibitions set forth in the Confidentiality, Non-Solicitation and Non-Compete Agreement attached as Addendum A and incorporated
into this Agreement shall inure to the benefit of any purchaser, assignor or transferee of this Agreement and shall continue to be enforceable to the extent allowable under applicable law. Neither this Agreement, nor the employment status conferred
with its execution is assignable or subject to transfer in any manner by Executive. 
 16. Notices. All notices, requests, demands, and other
communications shall be in writing and shall be given by registered or certified mail, postage prepaid, a) if to the Employer, at the Employer’s then current headquarters location, and b) if to Executive, at the most recent address on file with
the Company for Executive or to such subsequent addresses as either party shall so designate in writing to the other party. 
 17. Remedies. If
any action at law, equity or in arbitration, including an action for declaratory relief, is brought to enforce or interpret the provisions of this Agreement, the prevailing party may, if the court or arbitrator hearing the dispute, so determines,
have its reasonable attorneys’ fees and costs of enforcement recouped from the non-prevailing party. 
 18. Amendment/Waiver. No waiver,
modification, amendment or change of any term of this Agreement shall be effective unless it is in a written agreement signed by both parties. No waiver by the Employer of any breach or threatened breach of this Agreement shall be construed as a
waiver of any subsequent breach unless it so provides by its terms. 
 19. Governing Law, Venue and Jurisdiction. This Agreement and all
transactions contemplated by this Agreement shall be governed by, construed, and enforced in accordance with the laws of the State of Florida without regard to any conflicts of laws, statutes, rules, regulations or ordinances. Executive consents to
personal jurisdiction and venue in the Circuit Court in and for Lee County, Florida regarding any action arising under the terms of this Agreement and any and all other disputes between Executive and Employer. 

20. Arbitration. Any and all controversies and disputes between Executive and Employer arising from this Agreement or regarding any other matter
whatsoever shall be submitted to arbitration before a single unbiased arbitrator skilled in arbitrating such disputes under the American Arbitration Association, utilizing its Commercial Rules. Any arbitration action brought pursuant to this section
shall be heard in Fort Myers, Lee County, Florida. The Circuit Court in and for Lee County, Florida shall have concurrent jurisdiction with any arbitration panel for the purpose of entering temporary and permanent injunctive relief, but only with
respect to any alleged breach of the Confidentiality, Non-Solicitation and Non-Compete Agreement. 
 21. Headings. The titles to the sections
of this Agreement are solely for the convenience of the parties and shall not affect in any way the meaning or interpretation of this Agreement. 
 22.
Miscellaneous Terms. The parties to this Agreement declare and represent that: 
  

	 	a.	They have read and understand this Agreement; 

  

	 	b.	They have been given the opportunity to consult with an attorney if they so desire; 

  

	 	c.	They intend to be legally bound by the promises set forth in this Agreement and enter into it freely, without duress or coercion; 

  

	 	d.	They have retained signed copies of this Agreement for their records; and 


  
 8 









	 	e.	The rights, responsibilities and duties of the parties hereto, and the covenants and agreements contained herein, shall continue to bind the parties and shall continue in full force and effect until each and every
obligation of the parties under this Agreement has been performed. 

 23. Counterparts. This Agreement may be executed in
counterparts and by facsimile, or by pdf, each of which shall be deemed an original for all intents and purposes. 
 Signatures appear on
the following page. 

  
 9 








 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	NEOGENOMICS, INC., a Nevada Corporation
		
	By:	 	/s/ Douglas VanOort


 
			
		
	Name:	 	Douglas VanOort


 
			
		
	Title:	 	Chairman and CEO


  

	
	EXECUTIVE:
	
	/S/ Robert J. Shovlin
	Robert J. Shovlin



  
 10 








 Addendum A 

Form of Confidentiality, Non-Solicitation & Non-Compete Agreement 

  
 11